Your browser doesn't support javascript.
loading
Low-dose metronomic doxorubicin inhibits mobilization and differentiation of endothelial progenitor cells through REDD1-mediated VEGFR-2 downregulation.
Park, Minsik; Kim, Ji Yoon; Kim, Joohwan; Lee, Jeong-Hyung; Kwon, Young-Guen; Kim, Young-Myeong.
Affiliation
  • Park M; Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon 24341, Korea.
  • Kim JY; Department of Anaesthesiology and Pain Medicine, Hanyang University Hospital, Seoul 04763, Korea.
  • Kim J; Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon 24341, Korea.
  • Lee JH; Department of Biochemistry, Kangwon National University, Chuncheon 24341, Korea.
  • Kwon YG; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea.
  • Kim YM; Department of Molecular and Cellular Biochemistry, Kangwon National University School of Medicine, Chuncheon 24341, Korea.
BMB Rep ; 54(9): 470-475, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34488932
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Doxorubicin / Down-Regulation / Cell Differentiation / Vascular Endothelial Growth Factor Receptor-2 Type of study: Risk_factors_studies Limits: Animals Language: En Journal: BMB Rep Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Doxorubicin / Down-Regulation / Cell Differentiation / Vascular Endothelial Growth Factor Receptor-2 Type of study: Risk_factors_studies Limits: Animals Language: En Journal: BMB Rep Year: 2021 Document type: Article